Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZURE: Zoledronic acid in addition to adjuvant therapy for breast cancer
2004-000608-42Phase 3Completed
- Sponsor
- University of Sheffield
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of zoledronic acid in breast cancer (2 arms), sponsored by University of Sheffield. Primary endpoint: Disease-free survival. Started Nov 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-000608-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000608-42.